Phosphorylation of BCL-2 after exposure of human leukemic cells to retinoic acid

Blood

Volumn 92, Issue 5, 1998, Pages 1768-1775

  Hu, Z B ^a   Minden, M D ^a   McCulloch, E A ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; PROTEIN BCL 2; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; HUMAN; HUMAN CELL; ISOELECTRIC FOCUSING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 0032170074     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.5.1768.417k19_1768_1775     Document Type: Article

References (34)

1. Fisher DE: Apoptosis in cancer therapy: Crossing the threshold. Cell 78:539, 1994
2. Rowan S, Fisher DE: Mechanisms of apoptotic cell death. Leukemia 11:457, 1997
3. Gunji H, Kharbanda S, Kufe D: Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-β arabinofuranosylcytosine. Cancer Res 51:741, 1991
4. Haimovitz-Friedman A, Kan C-C, Ehleiter D, Persaud RS, McLoughlin M, Fuks Z, Kolesnick RN: Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med 180:525, 1994
5. Bose R, Verheij M, Haimovitz FA, Scotto K, Kolesnick R: Ceramide synthase mediates daunorubicin-induced apoptosis; an alternative mechanism for generating death signals. Cell 82:405, 1995
6. Koury MJ: Programmed cell death (apoptosis) in hemopoiesis. Exp Hematol 20:391, 1 992
7. Korsmeyer SJ: Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 80:879, 1992
8. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ: Bel-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 72:229, 1993
9. Yang E, Korsmeyer SJ: Molecular thanatopsis: A discourse on the bcl-2 family and cell death. Blood 88:386, 1996
10. Hockenbery D, Nunez G, Millman C, Schreiber RD, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334, 1990
11. Grillot DAM, Merino R, Nunez G: bcl-xl displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice. J Exp Med 182:1973, 1995
12. Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609, 1993
13. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ: Bad, a heterodimeric partner of Bcl-xl and bcl-2, displaces bax and promotes cell death. Cell 80:285, 1995
14. Yin X-M Oltvai ZN, Korsmeyer SJ: BH1 and BH2 domains of bcl-2 are required for inhibition of apoptosis and heterodimerization withBax. Nature 369:321, 1994
15. Haldar S, Jena N, Croce CM: Inactivation of bcl-2 by phosphorylation. Proc Natl Acad Sci USA 92:4507, 1995
16. Blagosklonny MV, Schulte T, Nguyen P, Trepel J, Neckers LM: Taxol-induced apoptosis and phosphorylation of bcl-2 protein involves c-raf-1 and represents a novel c-raf-1 signal transduction pathway. Cancer Res 56:1851, 1996
17. Haldar S, Chintapalli J, Croce CM: Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res 56:1253, 1996
18. L, an inhibitor of programmed cell death. Nature 381:335, 1996
19. L and bcl-2. EMBO J 16:968, 1997
20. Ito T, Deng X, Carr B, May WS: Bcl-2 phosphorylation required for anti-apoptosis function. J Biol Chem 272:11671, 1997
21. Lishner M, Curtis JE, Minkin S, McCulloch EA: Interaction between retinoic acid and cytosine arabinoside affecting the blast cells of acute myeloblastic leukemia. Leukemia 3:784, 1989
22. Yang GS, Minden MD, McCulloch EA: Regulation by retinoic acid and hydrocortisone of the anthracycline sensitivity of blast cells of acute myeloblastic leukemia. Leukemia 8:2065, 1994
23. Yang GS, Minden MD, McCulloch EA: Influence of schedule on regulated sensitivity of AML blasts to cytosine arabinoside. Leukemia 7:1012, 1993
24. Hu Z-B, Minden MD, McCulloch EA: Post-transcriptional regulation of bcl-2 in acute myeloblastic leukemia: Significance for response to chemotherapy. Leukemia 10:410, 1996
25. Hu Z-B, Yang GS, Li M, Miyamoto N, Minden MD, McCulloch EA: Mechanism of cytosine arabinoside toxicity to the blast cells of acute myelobiastic leukemia: Involvement of free radicals. Leukemia 9:789, 1995
26. Boyle WJ, van der Geer P, Hunter T: Phosphopeptide mapping and phosphoamino acid analysis by two dimensional separation on thin-layer cellulose plates. Methods Enzymol 201:110, 1991
27. Pulverer BJ, Fisher C, Vousden K, Littlewood T, Evan G, Woodgett JR: Site-specific modulation of c-Myc cotransformation by resides phosphorylated in vivo. Oncogene 9:59, 1994
28. Haldar S, Basu A, Croce CM: Bcl-2 is the guardian of microtubule integrity. Cancer Res 57:229, 1997
29. Maundrell K, Antonsson B, Magnenat E, Camps M, Muda M, Chabert C, GilJieron C, Beschert U, Vial-Knecht E, Martinous J-C, Arkinstall S: Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Racl. J Biol Chem 272:25238, 1997
30. L. Cell 87:619, 1996
31. Wang C, Curtis JE, Minden MD, McCulloch EA: Expression of a retinoic acid receptor gene in myeloid leukemia cells. Leukemia 3:264, 1989
32. Fenaux P, LeDeley MC, Castaigne S, Archambaud E, Chomienne C, Link H, Guerci A, Duater M, Daniel MT, Bowen Q: Effect of all trans retinoic acid in newly diagnosed acute promyelocyctic leukemia. Results of a multicentre randomized trial. Blood 82:3241, 1993
33. Huang M-E, Ye Y-C, Chen S-R, Chai J-R, Lu J-X, Zhoa L, Gu L-J, Wang Z-Y: Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567, 1988
34. Estey E, Beran M, Pierce S, Kantarjian H, Keating M: All-trans retinoic acid (ATRA) may improve results of chemotherapy in poorprognosis non-APL AML and MDS: A randomized study. Blood 90:416a, 1997 (abstr, suppl 1)